Ausgewählte Publikation

• Rago L, Beattie R, Taylor V, Winter J. (2014) miR379-410 cluster miRNAs regulate neurogenesis and neuronal migration by fine-tuning N-cadherin. EMBO J. 2014 Apr 16;33(8):906-20. doi: 10.1002/embj.201386591. Epub 2014 Mar 10.
• Pfeiffer A, Jaeckel M, Lewerenz J, Noack R, Pouya A, Schacht T, Hoffmann C, Winter J, Schweiger S, Schäfer MK, Methner A. (2014) Mitochondrial function and energy metabolism in neuronal HT22 cells resistant to oxidative stress. Br J Pharmacol. 2014 Apr;171(8):2147-58. doi: 10.1111/bph.12549.
• Bräutigam C, Raggioli A, Winter J. (2013) The Wnt/β-catenin pathway regulates the expression of the miR-302 cluster in mouse ESCs and P19 cells. PLoS One. 2013 Sep 10;8(9):e75315. doi: 10.1371/journal.pone.0075315. eCollection 2013.
• Bräutigam C, Rago L, Rolke A, Waldmeier L, Christofori G, Winter J. (2013)
• The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion. Oncogene. 2014 Feb 27;33(9):1082-92. doi: 10.1038/onc.2013.50. Epub 2013 Feb 25.
• Aranda-Orgilles B, Trockenbacher A, Winter J, Aigner J, Köhler A, Jastrzebska E, Stahl J, Müller EC, Otto A, Wanker EE, Schneider R, Schweiger S. (2008) The Opitz syndrome gene MID1 assembles a microtubule-associated ribonucleoprotein complex. Hum Genet. 2008 Mar;123(2):163-76. doi: 10.1007/s00439-007-0456-6. Epub 2008 Jan 3.
• Winter J, Roepcke S, Krause S, Müller EC, Otto A, Vingron M, Schweiger S. (2008) Comparative 3'UTR analysis allows identification of regulatory clusters that drive Eph/ephrin expression in cancer cell lines. PLoS One. 2008 Jul 23;3(7):e2780.
• Winter J, Kunath M, Roepcke S, Krause S, Schneider R, Schweiger S (2007) Alternative polyadenylation sites and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1. BMC Mol Biol. 2007 Nov 15;8:105.
• So J, Suckow V, Kijas Z, Kalscheuer V, Moser B, Winter J, Baars M, Firth H, Lunt P, Hamel B, Meinecke P, Moraine C, Odent S, Schinzel A, van der Smagt JJ, Devriendt K, Albrecht B, Gillessen-Kaesbach G, van der Burgt I, Petrij F, Faivre L,
• McGaughran J, McKenzie F, Opitz JM, Cox T, Schweiger S (2005) Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. Am J Med Genet A. 2005 Jan 1;132A(1):1-7.
• Winter J, Lehmann T, Krauß S, Trockenbacher A, Kijas Z, Foerster J, Suckow V, Yaspo M-L, Kulozik A, Kalscheuer V, Ropers HH, Schneider R, Schweiger S (2004) Regulation of the MID1 protein function is fine-tuned by a complex pattern of alternative splicing. Hum Genet 114: 541-552
• Winter J, Lehmann T, Suckow V, Kijas Z, Kulozik A, Kalscheuer V, Hamel B, Devriendt K, Opitz J, Lenzner S, Ropers HH, Schweiger S (2003) Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome. Hum Genet 112: 249-54
• Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, Schneider R, Schweiger S (2000) MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet. 2001 Nov;29(3):287-94. Erratum in: Nat Genet 2002 Jan;30(1):123.